Creo Medical shares climb 8% as patient testimonial highlights real-world benefits of Speedboat technology
Last updated: 07:30 04 Aug 2025 EDT, First published: 07:21 04 Aug 2025 EDT
Shares in Creo Medical Group PLC (AIM:CREO) rose 8% after the company published a powerful patient testimonial showcasing the real-world benefits of its Speedboat technology.
The video highlights the story of Liz Thomas, wife of a former Creo engineer, who was able to avoid major bowel surgery thanks to a minimally invasive Speedboat procedure.
Although the treatment was not initially available through NHS Wales, Liz accessed it privately in England, recovering within days and resuming normal life quickly.
The case underlines Speedboat's growing reputation for treating early-stage colorectal cancer without the need for extensive surgery, stitches or long recovery times.
The technology is now being piloted by Aneurin Bevan University Health Board in Wales, with early results pointing to strong patient outcomes.
Creo believes that continued success with the Welsh pilot will open the door for broader NHS adoption and support commercial growth.
The shares rose 0.95p to 13.45p.
To watch the video, click here.
